摘要
目的:验证国产低分子肝素钙(立迈青)用于血液透析(血透)抗凝的疗效和安全性。方法:15例患者作自身前后交叉对照观察,每例患者各使用立迈青或法安明(低分子肝素钠)进行血透5次,于血透开始时静脉推注立迈青或法安明5000抗FXaIU,不用维持量。结果:2组患者顺利完成血透各75例次;透析器容量(BCV)减少率、透析1h尿素即刻清除率、白陶土部分凝血活酶时间、血小板及抗FXa活性等2组间均无显著性差异(P>005)。结论:立迈青作为血透抗凝剂的疗效和安全性与法安明一致。
Objective:To compare the efficacy and safety of home made low
molecular weight heparin(Livaracine) with that of Fragmin.Methods:Fifteen hemodialysis
patients were studied in a radomized crossover fashion.All patients were randomized
into Livaracine and Fragmin in five times HD.Livaracine or Fragmin was given at the
initiation of hemodialysis in a single bolus dose of 5 000 anti FXa IU without
maintanent dose.Results:Seventy five dialysis procedures with either Livaracine or
Fragmin were performed successfully;blood compartment volume of dialyzers,1 hour
clearance of urea,activated partial thromboplastin time,blood platelets count,anti FXa
levels were comparable between these two groups( P >0 05).Conclusion:Livaracine was
effective and safe like as Fragmin.
出处
《中日友好医院学报》
1999年第1期33-36,共4页
Journal of China-Japan Friendship Hospital
关键词
肾功能衰竭
慢性
低分子肝素
血液透析
kidney failure,chronic
low molecular weight
heparin
hemodialysis